Donald F. Steiner, MD, 1930–2014 Kenneth S. PolonskyArthur H. Rubenstein In memoriam Open access 24 January 2015 Pages: 419 - 421
Fetal growth and the ethnic origins of type 2 diabetes Michael R. Skilton Commentary 08 January 2015 Pages: 422 - 424
Targeting 12-lipoxygenase as a novel strategy to combat the effects of inflammation on beta cells in diabetes Jan A. EhsesMarc Y. Donath Commentary 24 December 2014 Pages: 425 - 428
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes Silvio E. InzucchiRichard M. BergenstalDavid R. Matthews Position Statement 13 January 2015 Pages: 429 - 442
Epigenetic mechanisms in diabetic complications and metabolic memory Marpadga A. ReddyErli ZhangRama Natarajan Review 07 December 2014 Pages: 443 - 455
Role of islet microRNAs in diabetes: which model for which question? Claudiane GuayRomano Regazzi Review 16 December 2014 Pages: 456 - 463
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study Kwok-Leung OngAndrzej S. JanuszewskiKerry-Anne Rye Article 26 November 2014 Pages: 464 - 473
Birthweight and risk markers for type 2 diabetes and cardiovascular disease in childhood: the Child Heart and Health Study in England (CHASE) Claire M. NightingaleAlicja R. RudnickaPeter H. Whincup Article Open access 18 December 2014 Pages: 474 - 484
Dose–response relationships between sedentary behaviour and the metabolic syndrome and its components Keith P. GennusoRonald E. GangnonLisa H. Colbert Article 05 December 2014 Pages: 485 - 492
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis Daniel LevinSamira Bellon behalf of the Scottish Diabetes Research Network Epidemiology Group and the Diabetes and Cancer Research Consortium Article 07 December 2014 Pages: 493 - 504
Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study Evangelos KontopantelisDavid A. SpringateTim Doran Article 16 December 2014 Pages: 505 - 518
ABO and Rhesus blood groups and risk of type 2 diabetes: evidence from the large E3N cohort study Guy FagherazziGaëlle GustoFabrice Bonnet Short Communication 23 December 2014 Pages: 519 - 522
Fasting serum levels of ferritin are associated with impaired pancreatic beta cell function and decreased insulin sensitivity: a population-based study Linéa BonfilsChristina EllervikKristine H. Allin Article 14 December 2014 Pages: 523 - 533
Age trajectories of glycaemic traits in non-diabetic South Asian and white individuals: the Whitehall II cohort study Satoyo IkeharaAdam G. TabákEric J. Brunner Article Open access 28 November 2014 Pages: 534 - 542
SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes Marine GermainMarcus G. PezzolesiSamy Hadjadj Short Communication 06 December 2014 Pages: 543 - 548
Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunction David A. Taylor-FishwickJessica WeaverJerry L. Nadler Article 23 November 2014 Pages: 549 - 557
Ins1 Cre knock-in mice for beta cell-specific gene recombination Bernard ThorensDavid TarussioJorge Ferrer Article Open access 11 December 2014 Pages: 558 - 565
MafA is critical for maintenance of the mature beta cell phenotype in mice Wataru NishimuraSatoru TakahashiKazuki Yasuda Article 13 December 2014 Pages: 566 - 574
IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice Clara Y. Westwell-RoperCyrus A. ChehroudiC. Bruce Verchere Article 10 December 2014 Pages: 575 - 585
Glucose uptake in human brown adipose tissue is impaired upon fasting-induced insulin resistance Mark J. W. HanssenRoel WiertsWouter D. van Marken Lichtenbelt Article 13 December 2014 Pages: 586 - 595
Increased gluconeogenesis in youth with newly diagnosed type 2 diabetes Stephanie T. ChungDaniel S. HsiaMorey W. Haymond Article 03 December 2014 Pages: 596 - 603
GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice Robert W. SchwenkChristian BaumeierAnnette Schürmann Article Open access 20 December 2014 Pages: 604 - 614
Pre-gestational vs gestational exposure to maternal obesity differentially programs the offspring in mice Isaac E. SassonAlexa P. VitinsRebecca A. Simmons Article 11 December 2014 Pages: 615 - 624
Autophagy in the posterior interosseous nerve of patients with type 1 and type 2 diabetes mellitus: an ultrastructural study Ayman A. M. OsmanLars B. DahlinSimin Mohseni Article 19 December 2014 Pages: 625 - 632
Diabetes reduces mesenchymal stem cells in fracture healing through a TNFα-mediated mechanism Kang I. KoLeila S. CoimbraDana T. Graves Article 07 January 2015 Pages: 633 - 642
Erratum to: ‘Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice’ and ‘Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway’ C. ZhangC. McFarlaneR. Kambadur Erratum 11 December 2014 Pages: 643 - 643
Erratum to: Modulation of p75NTR prevents diabetes- and proNGF-induced retinal inflammation and blood–retina barrier breakdown in mice and rats Barbara A. MysonaMohammed M. H. Al-GayyarAzza B. El-Remessy Erratum 20 December 2014 Pages: 644 - 644